Cancer Immunotherapy Market Exploring Growth Opportunities and Challenges

The projected growth of the global cancer immunotherapy market is expected to reach a Compound Annual Growth Rate (CAGR) of 14.0%. This expansion is driven by several factors, including the increasing preference for targeted therapy over traditional methods, the emergence of biosimilars, growing demand for monoclonal antibodies (mAbs), and the high prevalence of cancer.